Developers: | Samara State Medical University (SamSMU) |
Branches: | Pharmaceuticals, Medicine, Healthcare |
Content |
History
2025: Product Announcement
Scientists of the Samara State Medical University of the Ministry of Health of Russia (SamGMU) have developed a unique line of author's hydrogels and biochernils that will allow printing cartilaginous and bone tissues, skin and mucous membranes on a 3D printer for use in reconstructive regenerative medicine. The creation of breakthrough technology was announced in May 2025.
According to Kommersant, innovative materials were created at the Samara Tissue Bank of the BioTech Research Institute of SamGMU using the patented Lyoplast ® technology. They are designed to develop personalized solutions in medicine and are created within the framework of the program of the Ministry of Education and Science of Russia "Priority-2030."
Nikolai Ryabov, senior researcher, head of the bioprinting laboratory at the BioTech Research Institute of SamGMU, noted that the main feature of the developed allogeneic biomaterials is their high biocompatibility, which significantly reduces the risk of rejection. This advantage distinguishes them favorably from xenogenic and synthetic analogues.
The developed biomaterials create optimal conditions for the repair of damaged tissues, fully complying with the principles of reparative regeneration - the process of natural restoration of cells and tissues after injury or during pathological processes. The uniqueness of the technology lies in the possibility of personalized selection of components for specific types of tissues or organs.
The range of applications of new developments in medicine is extremely wide. In traumatology, biomaterials will make it possible to recreate complex bone structures in fractures, creating personalized implants that accelerate healing and minimize the risk of rejection. In orthopedics, the technology will make it possible to print anatomically accurate cartilage constructs for joints, which will help slow down the development of arthrosis in patients with degenerative diseases.[1]